Published in Pharma Law Weekly, January 9th, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Kalorama Information.
Report 1: With steady growth over the last 10 years and a current assessment at $703 million, the China in vitro diagnostics market offers an increasingly attractive opportunity for manufacturers and distributors, according to a study released from Kalorama Information.
A changing Chinese healthcare environment with emphasis on privatization and China's accession to the World Trade Organization - with its resulting reduction in tariffs and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Pharma Law Weekly